Literature DB >> 1515366

Group-specific component (GC) polymorphism in Cádiz (southern Spain).

M A Vizcaya1, J L Romero, J J Gamero, M I Arufe.   

Abstract

The genetic polymorphism of group-specific component (GC) was analysed in a sample of 443 healthy unrelated subjects of both sexes resident in the province of Cádiz (Southern Spain). Isoelectric focusing was carried out in polyacrylamide gels followed by staining with coomassie blue R 250. The estimated gene frequencies were as follows: GC*1S = 0.6185; GC*1F = 0.1162; GC*2 = 0.2652.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515366     DOI: 10.1007/bf01369560

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  6 in total

1.  Genetic studies on the Gc subtypes.

Authors:  H Cleve; W Patutschnick; S Nevo; G G Wendt
Journal:  Hum Genet       Date:  1978-10-31       Impact factor: 4.132

2.  Distribution of the Pi, TfC, and Gc subtypes in Galicia (North West Spain).

Authors:  A Carracedo; L Concheiro
Journal:  Z Rechtsmed       Date:  1983

3.  Group-specific component: evidence for two subtypes of the Gc1 gene.

Authors:  J Constans; M Viau
Journal:  Science       Date:  1977-12-09       Impact factor: 47.728

4.  Analysis of the Gc polymorphism in human populations by isoelectrofocusing on polyacrylamide gels. Demonstration of subtypes of the Gc allele and of additional Gc variants.

Authors:  J Constans; M Viau; H Cleve; G Jaeger; J C Quilici; M J Palisson
Journal:  Hum Genet       Date:  1978-02-23       Impact factor: 4.132

5.  Population distribution of the human vitamin D binding protein: anthropological considerations.

Authors:  J Constans; S Hazout; R M Garruto; D C Gajdusek; E K Spees
Journal:  Am J Phys Anthropol       Date:  1985-09       Impact factor: 2.868

6.  Group-specific component (Gc) and transferrin (Tf) subtypes ascertained by isoelectric focusing. A simple nonimmunological staining procedure for Gc.

Authors:  B Hoste
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.